PLSE · Pulse Biosciences Inc Common Stock (DE)
View on chartInsiders & Stakes
| Robert W. Duggan Director | ▲ Buy | Open Market | 48,211,433 Shares held | 5/11/2026 | View profile |
| Mahkam Zanganeh Director | ▼ Sell | Other | 725,395 Shares held | 2/3/2025 | View profile |
| UECKER DARRIN Director | ▲ Buy | Option Exercise | 284,406 Shares held | 9/17/2025 | View profile |
| Barrett Burke Thomas President and CEO | ▼ Sell | Open Market | 63,172 Shares held | 12/11/2024 | View profile |
| Danahy Kevin Patrick Chief Executive Officer | ▼ Sell | Open Market | 43,298 Shares held | 2/18/2026 | View profile |
| Paul A. Laviolette Chief Executive Officer | ▲ Buy | Open Market | 15,000 Shares held | 5/11/2026 | View profile |
| Levinson Mitchell E. Chief Strategy Officer | ▼ Sell | Other | 8,521 Shares held | 9/24/2024 | View profile |
| Teplitsky Liane Rae Chief Operating Officer | ▲ Buy | Open Market | 4,095 Shares held | 9/1/2026 | View profile |
Transaction History
| Teplitsky Liane Rae | ▲ Buy | Open Market | 1,001 | $50K | 9/1/2026 |
| Teplitsky Liane Rae | ▲ Buy | Open Market | 1,024 | $50K | 8/31/2026 |
| Teplitsky Liane Rae | ▲ Buy | Open Market | 1,034 | $50K | 8/28/2026 |
| Teplitsky Liane Rae | ▲ Buy | Open Market | 1,036 | $50K | 8/26/2026 |
| Paul A. Laviolette | ▲ Buy | Open Market | 15,000 | $295K | 5/11/2026 |
| Robert W. Duggan | ▲ Buy | Open Market | 660,233 | $13.0M | 5/11/2026 |
| Danahy Kevin Patrick | ▲ Buy | Option Exercise | 5,000 | $8K | 2/18/2026 |
| Danahy Kevin Patrick | ▼ Sell | Open Market | 5,000 | $118K | 2/18/2026 |
| Danahy Kevin Patrick | ▲ Buy | Option Exercise | 20,000 | $31K | 2/17/2026 |
| Danahy Kevin Patrick | ▼ Sell | Open Market | 20,000 | $473K | 2/17/2026 |
| Danahy Kevin Patrick | ▲ Buy | Option Exercise | 20,000 | $31K | 2/13/2026 |
| Danahy Kevin Patrick | ▼ Sell | Open Market | 20,000 | $471K | 2/13/2026 |
| Danahy Kevin Patrick | ▲ Buy | Option Exercise | 20,000 | $31K | 2/12/2026 |
| Danahy Kevin Patrick | ▼ Sell | Open Market | 20,000 | $467K | 2/12/2026 |
| Danahy Kevin Patrick | ▲ Buy | Option Exercise | 20,000 | $31K | 2/11/2026 |
| Danahy Kevin Patrick | ▼ Sell | Open Market | 20,000 | $504K | 2/11/2026 |
| Danahy Kevin Patrick | ▲ Buy | Option Exercise | 20,000 | $31K | 2/10/2026 |
| Danahy Kevin Patrick | ▼ Sell | Open Market | 20,000 | $470K | 2/10/2026 |
| Danahy Kevin Patrick | ▲ Buy | Option Exercise | 20,000 | $31K | 2/9/2026 |
| Danahy Kevin Patrick | ▼ Sell | Open Market | 20,000 | $429K | 2/9/2026 |
| Danahy Kevin Patrick | ▲ Buy | Option Exercise | 4,600 | $7K | 10/2/2025 |
| Danahy Kevin Patrick | ▼ Sell | Open Market | 4,600 | $85K | 10/2/2025 |
| Danahy Kevin Patrick | ▼ Sell | Open Market | 400 | $7K | 9/19/2025 |
| Danahy Kevin Patrick | ▲ Buy | Option Exercise | 400 | $612 | 9/19/2025 |
| Danahy Kevin Patrick | ▲ Buy | Option Exercise | 20,000 | $31K | 9/18/2025 |
| Danahy Kevin Patrick | ▼ Sell | Open Market | 20,000 | $370K | 9/18/2025 |
| UECKER DARRIN | ▲ Buy | Option Exercise | 20,000 | $80K | 9/17/2025 |
| UECKER DARRIN | ▼ Sell | Open Market | 20,000 | $324K | 9/17/2025 |
| UECKER DARRIN | ▲ Buy | Option Exercise | 61,534 | $246K | 9/17/2025 |
| UECKER DARRIN | ▲ Buy | Option Exercise | 100,000 | $400K | 9/17/2025 |
| UECKER DARRIN | ▲ Buy | Option Exercise | 25,000 | $100K | 9/16/2025 |
| UECKER DARRIN | ▼ Sell | Open Market | 25,000 | $407K | 9/16/2025 |
| UECKER DARRIN | ▼ Sell | Open Market | 25,000 | $394K | 9/15/2025 |
| UECKER DARRIN | ▲ Buy | Option Exercise | 25,000 | $100K | 9/15/2025 |
| UECKER DARRIN | ▼ Sell | Open Market | 25,000 | $358K | 9/12/2025 |
| UECKER DARRIN | ▲ Buy | Option Exercise | 25,000 | $100K | 9/12/2025 |
| UECKER DARRIN | ▲ Buy | Option Exercise | 25,000 | $100K | 9/11/2025 |
| UECKER DARRIN | ▼ Sell | Open Market | 25,000 | $370K | 9/11/2025 |
| Robert W. Duggan | ▲ Buy | Open Market | 34,659 | $508K | 9/10/2025 |
| UECKER DARRIN | ▼ Sell | Open Market | 15,000 | $240K | 6/13/2025 |
| UECKER DARRIN | ▼ Sell | Open Market | 15,000 | $246K | 6/12/2025 |
| Mahkam Zanganeh | ▼ Sell | Other | 30,121 | $331K | 2/3/2025 |
| Mahkam Zanganeh | ▼ Sell | Other | 30,121 | $331K | 1/24/2025 |
| Robert W. Duggan | ▼ Sell | Other | 49,312 | $542K | 12/18/2024 |
| Robert W. Duggan | ▼ Sell | Other | 5,187,824 | $57.1M | 12/18/2024 |
| Robert W. Duggan | ▼ Sell | Other | 69,020 | $759K | 12/18/2024 |
| Robert W. Duggan | ▲ Buy | Open Market | 55,256 | $949K | 12/13/2024 |
| Robert W. Duggan | ▲ Buy | Open Market | 45,404 | $778K | 12/12/2024 |
| Barrett Burke Thomas | ▼ Sell | Open Market | 50,000 | $871K | 12/11/2024 |
| Robert W. Duggan | ▲ Buy | Open Market | 6,054 | $101K | 12/11/2024 |
| Robert W. Duggan | ▲ Buy | Open Market | 50,000 | $871K | 12/11/2024 |
| Levinson Mitchell E. | ▼ Sell | Other | 1,240 | $14K | 9/24/2024 |
| Levinson Mitchell E. | ▼ Sell | Other | 322 | $4K | 9/24/2024 |
| Levinson Mitchell E. | ▼ Sell | Other | 322 | $4K | 9/24/2024 |
| Levinson Mitchell E. | ▼ Sell | Other | 322 | $4K | 9/24/2024 |
| Levinson Mitchell E. | ▼ Sell | Other | 3,000 | $33K | 9/24/2024 |
| Robert W. Duggan | ▲ Buy | Open Market | 145,140 | $2.1M | 9/12/2024 |
| Robert W. Duggan | ▲ Buy | Open Market | 12,800 | $189K | 9/11/2024 |
| Barrett Burke Thomas | ▼ Sell | Other | 543 | $6K | 7/19/2024 |
| Barrett Burke Thomas | ▼ Sell | Other | 543 | $6K | 7/19/2024 |
| Barrett Burke Thomas | ▼ Sell | Other | 1,086 | — | 7/3/2024 |
| Levinson Mitchell E. | ▼ Sell | Other | 322 | — | 7/3/2024 |
| Levinson Mitchell E. | ▼ Sell | Other | 3,000 | — | 7/3/2024 |
| Levinson Mitchell E. | ▼ Sell | Other | 322 | — | 7/3/2024 |
| Robert W. Duggan | ▼ Sell | Other | 69,020 | — | 7/3/2024 |
| Levinson Mitchell E. | ▼ Sell | Other | 1,241 | — | 7/3/2024 |
| Levinson Mitchell E. | ▼ Sell | Other | 322 | — | 7/3/2024 |
| Danahy Kevin Patrick | ▼ Sell | Other | 650 | — | 7/3/2024 |
| Robert W. Duggan | ▼ Sell | Other | 5,187,824 | — | 7/3/2024 |
| Robert W. Duggan | ▼ Sell | Other | 49,312 | — | 7/3/2024 |
| Mahkam Zanganeh | ▼ Sell | Other | 60,242 | — | 7/3/2024 |
| Barrett Burke Thomas | ▲ Buy | Open Market | 10,000 | $86K | 5/20/2024 |
| Robert W. Duggan | ▲ Buy | Open Market | 17,999 | $165K | 12/12/2023 |
| Robert W. Duggan | ▲ Buy | Open Market | 90,118 | $844K | 12/11/2023 |
| Robert W. Duggan | ▲ Buy | Open Market | 116,656 | $1.1M | 12/8/2023 |
| Robert W. Duggan | ▲ Buy | Open Market | 74,852 | $688K | 12/7/2023 |
| Robert W. Duggan | ▲ Buy | Open Market | 82,813 | $750K | 12/6/2023 |
| Robert W. Duggan | ▲ Buy | Option Exercise | 9,933 | $59K | 12/6/2023 |
| Robert W. Duggan | ▲ Buy | Open Market | 66,021 | $617K | 12/5/2023 |
| Robert W. Duggan | ▲ Buy | Option Exercise | 20,000 | $213K | 12/4/2023 |
| Robert W. Duggan | ▲ Buy | Option Exercise | 20,347 | $217K | 12/4/2023 |
| Robert W. Duggan | ▲ Buy | Open Market | 27,000 | $280K | 12/4/2023 |
| Robert W. Duggan | ▲ Buy | Open Market | 45,600 | $414K | 12/1/2023 |
| Robert W. Duggan | ▲ Buy | Open Market | 152,944 | $1.4M | 11/30/2023 |
| Robert W. Duggan | ▲ Buy | Option Exercise | 1,667 | $10K | 11/29/2023 |
| Robert W. Duggan | ▲ Buy | Open Market | 158,600 | $1.5M | 11/29/2023 |
| Robert W. Duggan | ▲ Buy | Open Market | 60,000 | $553K | 11/29/2023 |
| Robert W. Duggan | ▲ Buy | Open Market | 124,397 | $1.1M | 11/28/2023 |
| Robert W. Duggan | ▲ Buy | Open Market | 241 | $1K | 11/17/2023 |
| Robert W. Duggan | ▲ Buy | Open Market | 10,000 | $61K | 11/17/2023 |
| Robert W. Duggan | ▲ Buy | Open Market | 10,000 | $61K | 11/17/2023 |
| Danahy Kevin Patrick | ▲ Buy | Open Market | 4,781 | $31K | 11/16/2023 |
| Danahy Kevin Patrick | ▲ Buy | Open Market | 600 | $4K | 11/16/2023 |
| Danahy Kevin Patrick | ▲ Buy | Open Market | 12 | $78 | 11/16/2023 |
| Levinson Mitchell E. | ▲ Buy | Open Market | 5,000 | $30K | 11/15/2023 |
| Levinson Mitchell E. | ▲ Buy | Open Market | 461 | $3K | 11/15/2023 |
| Levinson Mitchell E. | ▲ Buy | Open Market | 3,800 | $22K | 11/15/2023 |
| Levinson Mitchell E. | ▲ Buy | Open Market | 200 | $1K | 11/15/2023 |
| Levinson Mitchell E. | ▲ Buy | Open Market | 2,300 | $14K | 11/15/2023 |
| Levinson Mitchell E. | ▲ Buy | Open Market | 100 | $594 | 11/15/2023 |
| Levinson Mitchell E. | ▲ Buy | Open Market | 2,400 | $14K | 11/15/2023 |
| Levinson Mitchell E. | ▲ Buy | Open Market | 2,400 | $14K | 11/15/2023 |
| Levinson Mitchell E. | ▲ Buy | Open Market | 1,039 | $6K | 11/15/2023 |
| Levinson Mitchell E. | ▲ Buy | Open Market | 100 | $590 | 11/15/2023 |
| Mahkam Zanganeh | ▲ Buy | Option Exercise | 20,000 | $43K | 11/13/2023 |
| Mahkam Zanganeh | ▲ Buy | Option Exercise | 56,075 | $120K | 11/13/2023 |
| Robert W. Duggan | ▲ Buy | Option Exercise | 3,333 | $20K | 11/7/2023 |
| Robert W. Duggan | ▲ Buy | Option Exercise | 9,932 | $59K | 11/7/2023 |
| Robert W. Duggan | ▲ Buy | Option Exercise | 1,667 | $10K | 8/25/2023 |
| Robert W. Duggan | ▲ Buy | Option Exercise | 1,667 | $10K | 7/25/2023 |
| Robert W. Duggan | ▲ Buy | Option Exercise | 1,666 | $10K | 7/7/2023 |
| Robert W. Duggan | ▲ Buy | Option Exercise | 65,467 | $140K | 7/7/2023 |
| Robert W. Duggan | ▲ Buy | Option Exercise | 65,000 | $139K | 7/5/2023 |
| Robert W. Duggan | ▼ Sell | Other | 5,683,163 | $11.7M | 6/14/2023 |
| Robert W. Duggan | ▼ Sell | Other | 81,025 | $166K | 6/14/2023 |
| UECKER DARRIN | ▼ Sell | Other | 7,365 | $15K | 6/12/2023 |
| Mahkam Zanganeh | ▼ Sell | Other | 86,668 | $178K | 6/9/2023 |
| Levinson Mitchell E. | ▼ Sell | Other | 143 | $293 | 5/25/2023 |
| Levinson Mitchell E. | ▼ Sell | Other | 143 | $293 | 5/25/2023 |
| Levinson Mitchell E. | ▼ Sell | Other | 10,935 | $22K | 5/25/2023 |
| Levinson Mitchell E. | ▼ Sell | Other | 814 | $2K | 5/25/2023 |
| Levinson Mitchell E. | ▼ Sell | Other | 143 | $293 | 5/25/2023 |
| Robert W. Duggan | ▲ Buy | Open Market | 10,022,937 | $65.2M | 5/9/2023 |
| Levinson Mitchell E. | ▲ Buy | Open Market | 8,810 | $20K | 10/7/2022 |
| Levinson Mitchell E. | ▲ Buy | Open Market | 4,500 | $10K | 10/7/2022 |
| Levinson Mitchell E. | ▲ Buy | Open Market | 4,300 | $10K | 10/7/2022 |
| Levinson Mitchell E. | ▲ Buy | Open Market | 8,770 | $20K | 10/7/2022 |
| Levinson Mitchell E. | ▲ Buy | Open Market | 4,400 | $10K | 10/7/2022 |
| Danahy Kevin Patrick | ▲ Buy | Open Market | 6,500 | $15K | 9/30/2022 |
| Levinson Mitchell E. | ▼ Sell | Other | 814 | — | 6/9/2022 |
| Levinson Mitchell E. | ▼ Sell | Other | 143 | — | 6/9/2022 |
| UECKER DARRIN | ▼ Sell | Other | 7,365 | — | 6/9/2022 |
| Levinson Mitchell E. | ▼ Sell | Other | 143 | — | 6/9/2022 |
| Levinson Mitchell E. | ▼ Sell | Other | 143 | — | 6/9/2022 |
| Mahkam Zanganeh | ▼ Sell | Other | 86,668 | — | 6/9/2022 |
| Levinson Mitchell E. | ▼ Sell | Other | 10,935 | — | 6/9/2022 |
| Robert W. Duggan | ▼ Sell | Other | 81,025 | — | 6/9/2022 |
| Robert W. Duggan | ▼ Sell | Other | 5,683,163 | — | 6/9/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Pulse Biosciences Partners with Clayman Thyroid Center
Pulse Biosciences announced a commercial and clinical partnership with the Clayman Thyroid Center in Tampa, Florida. Additionally, Oppenheimer raised its price target to $60 and maintained an Outperform rating, citing the importance of the 2027 trial readout for the company's new ablation modality. The stock recently saw a 12.3% rise following the completion of full enrollment for the NANOPULSE-AF trial.
Pulse Biosciences Partners with Clayman Thyroid Center. Pulse Biosciences announced a commercial and clinical partnership with the Clayman Thyroid Center in Tampa, Florida. Additionally, Oppenheimer raised its price target to $60 and maintained an Outperform rating, citing the importance of the 2027 trial readout for the company's new ablation modality. The stock recently saw a 12.3% rise following the completion of full enrollment for the NANOPULSE-AF trial.